{"DataElement":{"publicId":"5918250","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Nodular Quantity Count","preferredDefinition":"The quantity or number of nodular malignant neoplasms (lesions) in Kaposi Sarcoma.","longName":"KP_MAL_NOD_CT","context":"CITN","contextVersion":"1","DataElementConcept":{"publicId":"5918249","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Nodular Neoplasm Quantity","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS)._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._A benign or malignant neoplasm characterized by the formation of nodules by the proliferating neoplastic cells._How much there is of something that you can measure; the total amount or number.","longName":"2640017v1.0:5918247v1.0","context":"CITN","contextVersion":"1","ObjectClass":{"publicId":"2640017","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin however, it may also occur internally.  It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9087:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FA69F5-9B59-3F85-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"ONEDATA","dateModified":"2007-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5918247","version":"1","preferredName":"Nodular Neoplasm Quantity","preferredDefinition":"A benign or malignant neoplasm characterized by the formation of nodules by the proliferating neoplastic cells.:How much there is of something that you can measure; the total amount or number.","longName":"C36012:C25256","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nodular Neoplasm","conceptCode":"C36012","definition":"A benign or malignant neoplasm characterized by the formation of nodules by the proliferating neoplastic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Quantity","conceptCode":"C25256","definition":"How much there is of something that you can measure; the total amount or number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55F00740-6A18-0498-E053-F662850A273B","latestVersionIndicator":"Yes","beginDate":"2017-08-04","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-08-04","modifiedBy":"ONEDATA","dateModified":"2017-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55F00740-6A29-0498-E053-F662850A273B","latestVersionIndicator":"Yes","beginDate":"2017-08-04","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-08-04","modifiedBy":"SOKKERL","dateModified":"2017-08-14","changeDescription":"8/4/17 LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5918221","version":"1","preferredName":"Count","preferredDefinition":"the quantity of the specified item.","longName":"5918221v1.0","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261845","version":"1","preferredName":"Count","preferredDefinition":"To determine the number or amount of something; the result of this activity.","longName":"C25463","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Count","conceptCode":"C25463","definition":"Determining the number or amount of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-646B-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-13","modifiedBy":"ONEDATA","dateModified":"2005-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55F0C5DA-FDEC-0CF5-E053-F662850A29C8","latestVersionIndicator":"Yes","beginDate":"2017-08-04","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-08-04","modifiedBy":"SOKKERL","dateModified":"2017-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"CITN - 1","type":"Alternate Question Text","description":"Number Nodular lesion","url":null,"context":"CITN"},{"name":"CITN - 2","type":"Alternate Question Text","description":"Totals","url":null,"context":"CITN"},{"name":"Nodular Lesion Total","type":"Preferred Question Text","description":"Nodular Lesion Total","url":null,"context":"CITN"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55F131EB-9534-6BA7-E053-F662850A1F9C","latestVersionIndicator":"Yes","beginDate":"2017-08-04","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-08-04","modifiedBy":"SOKKERL","dateModified":"2017-08-14","changeDescription":"8/4/17 LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}